Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Allison Whitten Pfizer's LITFULO meets primary endpoints in Phase 3 vitiligo trials Pfizer reported topline results from two Phase 3 trials of LITFULO (ritlecitinib) in nonsegmental vitiligo, with both the 50 and 100 milligram once-daily doses meeting co-primary endpoints for facial and total body repigmentation over placebo at Week 52
The role of AMPK in macrophage metabolism, function and polarisation
Ipamorelin is a pentapeptide five amino acids with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH and a molecular weight of 711.86 g/mol, first described in 1998
A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation
US$ 20.67
US$ 20.52
US$ 27.90
US$ 22.03
US$ 26.95
US$ 22.23
